Sign Out
Empagliflozin + Metformin HCl (JARDIANCE DUO) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin is appropriate (see Pharmacology: Clinical Trials under Actions and Dosage & Administration).
Paediatric population: Empagliflozin + Metformin HCl (JARDIANCE DUO) is indicated as an adjunct to diet and exercise to improve glycaemic control in children aged 10 years and above with type 2 diabetes mellitus.
When treatment with both empagliflozin and metformin is appropriate; inadequately controlled with metformin alone or in combination with insulin (see Pharmacology: Clinical Trials under Actions); already treated with empagliflozin and metformin co-administered as separate tablets.
Empagliflozin is indicated in adults with type 2 diabetes mellitus and established cardiovascular disease to reduce the risk of cardiovascular death (see Pharmacology: Clinical Trials under Actions).
To prevent cardiovascular deaths, empagliflozin should be used in conjunction with other measures to reduce cardiovascular risk in line with current standard of care.
Continue with Google